Lagard Camille, Vodovar Dominique, Chevillard Lucie, Callebert Jacques, Caillé Fabien, Pottier Géraldine, Liang Hao, Risède Patricia, Tournier Nicolas, Mégarbane Bruno
Inserm, UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, F-75006 Paris, France.
Department of Medical and Toxicological Critical Care, AP-HP, Lariboisière Hospital, 75010 Paris, France.
Pharmaceuticals (Basel). 2022 Oct 12;15(10):1254. doi: 10.3390/ph15101254.
Tramadol overdose is frequently associated with the onset of seizures, usually considered as serotonin syndrome manifestations. Recently, the serotoninergic mechanism of tramadol-attributed seizures has been questioned. This study’s aim was to identify the mechanisms involved in tramadol-induced seizures in overdose in rats. The investigations included (1) the effects of specific pretreatments on tramadol-induced seizure onset and brain monoamine concentrations, (2) the interaction between tramadol and γ-aminobutyric acid (GABA)A receptors in vivo in the brain using positron emission tomography (PET) imaging and 11C-flumazenil. Diazepam abolished tramadol-induced seizures, in contrast to naloxone, cyproheptadine and fexofenadine pretreatments. Despite seizure abolishment, diazepam significantly enhanced tramadol-induced increase in the brain serotonin (p < 0.01), histamine (p < 0.01), dopamine (p < 0.05) and norepinephrine (p < 0.05). No displacement of 11C-flumazenil brain kinetics was observed following tramadol administration in contrast to diazepam, suggesting that the observed interaction was not related to a competitive mechanism between tramadol and flumazenil at the benzodiazepine-binding site. Our findings do not support the involvement of serotoninergic, histaminergic, dopaminergic, norepinephrine or opioidergic pathways in tramadol-induced seizures in overdose, but they strongly suggest a tramadol-induced allosteric change of the benzodiazepine-binding site of GABAA receptors. Management of tramadol-poisoned patients should take into account that tramadol-induced seizures are mainly related to a GABAergic pathway.
曲马多过量常与癫痫发作相关,通常被认为是血清素综合征的表现。最近,曲马多所致癫痫发作的血清素能机制受到质疑。本研究的目的是确定大鼠曲马多过量致癫痫发作所涉及的机制。研究包括:(1)特定预处理对曲马多诱发癫痫发作起始及脑单胺浓度的影响;(2)利用正电子发射断层扫描(PET)成像和11C-氟马西尼,在体内研究曲马多与大脑γ-氨基丁酸(GABA)A受体之间的相互作用。与纳洛酮、赛庚啶和非索非那定预处理不同,地西泮可消除曲马多诱发的癫痫发作。尽管癫痫发作被消除,但地西泮显著增强了曲马多引起的脑血清素(p < 0.01)、组胺(p < 0.01)、多巴胺(p < 0.05)和去甲肾上腺素(p < 0.05)升高。与地西泮不同,曲马多给药后未观察到11C-氟马西尼脑动力学的位移,这表明所观察到的相互作用与曲马多和氟马西尼在苯二氮䓬结合位点的竞争机制无关。我们的研究结果不支持血清素能、组胺能、多巴胺能、去甲肾上腺素能或阿片样物质能途径参与曲马多过量致癫痫发作,但强烈提示曲马多诱导GABAA受体苯二氮䓬结合位点发生变构变化。曲马多中毒患者的治疗应考虑到曲马多诱发的癫痫发作主要与GABA能途径有关。